Biotech in the EU Work Programme for 2026 

The recently published European Commission’s 2026 Work Programme is packed with opportunities for a strong biotech sector: the European Innovation Act, Advanced Materials Act, European Research Area Act, and new initiatives on AI, critical raw materials, and the circular economy – to name a few. Most important is of course the EU Biotech Act, which the Commission has now officially split in two. Biotech Act I (expected before Christmas) focuses on rapid regulatory simplification in health, food and feed, enabling quick progress for innovation in those fields. Biotech Act II (expected Q3 2026) will deliver a comprehensive, future-proof framework for the entire biotech ecosystem, including industrial biotech, based on a full impact assessment. The coming year offers a unique opportunity to help shape Europe’s biotech future. During this time, hollandbio will continue to push for bold EU action, ensuring that this potential translates into real progress for a world-leading, innovation driven biotech landscape.